Blood plasma therapy does not reduce the risk of death in Covid-19 patients

Highlights

• Blood plasma therapy not useful for seriously ill patients
• The study was carried out in 72 hospitals  

Convalescent plasma does not reduce the risk of death in patients suffering from COVID-19, according to a study. People receiving the therapy are found to be experiencing more adverse events as compared to the ones who are receiving standard care.

This r....